(EDAP) MKap $56M //Heilung für Prostatakrebs nahe US-Zulassung (Seite 78)
eröffnet am 01.10.13 22:36:23 von
neuester Beitrag 04.03.24 14:24:13 von
neuester Beitrag 04.03.24 14:24:13 von
Beiträge: 1.134
ID: 1.186.741
ID: 1.186.741
Aufrufe heute: 0
Gesamt: 147.333
Gesamt: 147.333
Aktive User: 0
ISIN: US2683111072 · WKN: 908548 · Symbol: EDAP
7,1000
USD
+0,42 %
+0,0300 USD
Letzter Kurs 11.05.24 UTP Consolidated
Neuigkeiten
06.05.24 · globenewswire  |
02.05.24 · globenewswire |
23.04.24 · globenewswire |
27.03.24 · globenewswire |
13.03.24 · globenewswire |
Werte aus der Branche Dienstleistungen
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 89,00 | +34,83 | |
| 9,3250 | +19,55 | |
| 37,60 | +10,23 | |
| 0,9350 | +9,36 | |
| 0,6720 | +9,27 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 37,16 | -9,06 | |
| 26.300,00 | -9,31 | |
| 5.600,00 | -9,68 | |
| 12,000 | -17,24 | |
| 14,000 | -26,32 |
Beitrag zu dieser Diskussion schreiben
Feedback
Game over. Money lost.
Prostate Cancer Probe to Ease Impotence Opposed by Panel
By Anna Edney Jul 30, 2014 10:26 PM GMT+0200
An ultrasound device used in Europe to treat prostate cancer with lower rates of erectile dysfunction failed to win the recommendation of advisers to U.S. regulators who will decide whether the product becomes available to American men.
The device’s manufacturer EDAP TMS SA (EDAP) didn’t provide evidence the product is safe and effective, advisers to the Food and Drug Administration voted today. The device, called Ablatherm, is an alternative to traditional surgical and radiation treatments, and uses a robotic arm to insert a high-intensity, focused ultrasound device that heats and kills cancer cells.
While the company said Ablatherm produces lower rates of side effects than traditional treatments, an FDA staff report released July 28 questioned whether EDAP’s methods for testing are adequate. The French manufacturer compared patients in two different studies to gather evidence, rather than conduct a head-to-head trial, the FDA said.
To contact the reporter on this story: Anna Edney in Washington at aedney@bloomberg.net
To contact the editors responsible for this story: Reg Gale at rgale5@bloomberg.net Andrew Pollack, Angela Zimm
By Anna Edney Jul 30, 2014 10:26 PM GMT+0200
An ultrasound device used in Europe to treat prostate cancer with lower rates of erectile dysfunction failed to win the recommendation of advisers to U.S. regulators who will decide whether the product becomes available to American men.
The device’s manufacturer EDAP TMS SA (EDAP) didn’t provide evidence the product is safe and effective, advisers to the Food and Drug Administration voted today. The device, called Ablatherm, is an alternative to traditional surgical and radiation treatments, and uses a robotic arm to insert a high-intensity, focused ultrasound device that heats and kills cancer cells.
While the company said Ablatherm produces lower rates of side effects than traditional treatments, an FDA staff report released July 28 questioned whether EDAP’s methods for testing are adequate. The French manufacturer compared patients in two different studies to gather evidence, rather than conduct a head-to-head trial, the FDA said.
To contact the reporter on this story: Anna Edney in Washington at aedney@bloomberg.net
To contact the editors responsible for this story: Reg Gale at rgale5@bloomberg.net Andrew Pollack, Angela Zimm
Voting soll doch erst 23:40 MEZ starten.
Klar aber ein 50/50 Entscheidung wäre wie gesagt super gewesen
Wird allerdings gerade viel Müll im Yahoo Forum gepostet ....
einige sagen das alle Fragen negativ sind andere das, noch kein Voting gestartet worden ist
einige sagen das alle Fragen negativ sind andere das, noch kein Voting gestartet worden ist
Trading Spotlight
Wer rechnet den hier mit einem positiven Entscheid, der Kurs sprach Bände von knapp 6$ auf gut 3$.
Laut Yahoo Board alle drei Fragen mit negativen Voting ......
Question 1 = 3 Yes, 5 No, 2 Abstained
Question 2 = Unanimous No
Question 3 = Not even close
Question 1 = 3 Yes, 5 No, 2 Abstained
Question 2 = Unanimous No
Question 3 = Not even close
Handel wieder aktiv?
Antwort auf Beitrag Nr.: 47.402.562 von bherdzina am 30.07.14 21:16:04Kurz vorher hat der Kurs leicht angezogen sehe ich positiv. Außerdem macht ein TH für mich bei einem negativen Spruch wenig Sinn.Hoffen wir das Beste.
Gruß aaahhh
Gruß aaahhh
https://twitter.com/BioRunUp/status/494557586092347392
Hop oder Top ...ich denke eine 50 / 50 Entscheidung wäre schon als positiv anzusehen ...nachdem Kursverlauf der letzten Tage
Hop oder Top ...ich denke eine 50 / 50 Entscheidung wäre schon als positiv anzusehen ...nachdem Kursverlauf der letzten Tage
Durchsuchen
